|Articles|June 1, 1999
Supplements and Featured Publications
- Clinical and Economic Impact of Breast Cancer Treatment and Prevention in High-Risk Women
- Volume 5
- Issue 6 Suppl
Bibliography
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Medical and Economic Impact of Breast Cancer Treatment and Preventionabout 27 years ago
Benefits Foregone: Too Much of the Wrong and Too Little of the Rightabout 27 years ago
Breast Cancer Epidemiology: An Overviewabout 27 years ago
Overview of Cancer Economicsabout 27 years ago
Breast Cancer Stage Cost Analysis in a Managed Care Populationabout 27 years ago
The Cost Effectiveness of Tamoxifen in the Prevention of Breast Cancerabout 27 years ago
Question-and-Answer SessionAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year
3
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
4
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
5